SA Pharmaceutical Journal - Volume 79, Issue 1, 2012
Volume 79, Issue 1, 2012
Author Lorraine OsmanSource: SA Pharmaceutical Journal 79 (2012)More Less
I hope the new year (so-called) is treating you well! I must say that I'm feeling good, rested and relaxed, despite having spent some time in Cape Town! So, is it going to be "same old, same old", or is there going to be something new, exciting and interesting? I guess it's up to us.
Author Sybil SeokaSource: SA Pharmaceutical Journal 79 (2012)More Less
Welcome back from a well-deserved break! I hope we all had a super time to revitalise and rejuvenate ourselves. When I read the above text from Insider secrets by Fleet Street Publications, I could not help but think of the PSSA. I guess it also applies to our personal lives. Indeed, hope without action produces nothing. We have to really start doing things. Related to this is the saying, along the lines: "Stupidity is doing the same thing over and over again, and expecting a different result".
Source: SA Pharmaceutical Journal 79, pp 7 –11 (2012)More Less
One of the strategic objectives of the Pharmaceutical Society of South Africa (PSSA) is to monitor policy and legislation changes that will affect its members. In 2011, the Minister of Health published two vitally important documents for public comment, viz. the National Health Amendment Bill, and the Green Paper on National Health Insurance.
Source: SA Pharmaceutical Journal 79 (2012)More Less
The Pharmaceutical Society of South Africa (PSSA) welcomes the following pharmacists who joined the Society in October, November and December 2011. We trust that you will be welcomed into your branches and sectors, and that you will find great value in your membership.
Author Natalie SchellackSource: SA Pharmaceutical Journal 79, pp 14 –19 (2012)More Less
Gastro-oesophageal reflux disease (GORD) is a condition that affects more than half of all children. It is often difficult to diagnose, because the line between physiological and pathological GORD is very thin indeed. The signs and symptoms should be assessed according to the relevant age, and in younger children, it may be more difficult to diagnose, due to a lack of effective communication. Diagnosis relies on an accurate history provided by the parents or caregivers. Invasive diagnostic procedures, such as pH probe-testing, may be carried out to confirm the diagnosis. Initial management consists of dietary modifications, especially in physiological GORD, and as supplemental therapy, in pathological GORD. Pharmacological treatment consists mostly of H2-receptor blockers, proton-pump inhibitors (PPIs) and pro-kinetic agents, although preference is given to the PPIs, due to their healing effects in erosive oesophagitis.
Author Haley SmithSource: SA Pharmaceutical Journal 79, pp 20 –23 (2012)More Less
Insomnia is a common condition which includes trouble falling, or staying, asleep. This condition can range from being mild to severe, depending on how often it occurs, and for how long. The main focus of treatment for insomnia should be directed towards finding the underlying cause. Once a cause is identified, it is important to manage and control the underlying problem, as this alone may be able to eliminate the insomnia. Treating the symptoms of insomnia, without addressing the underlying cause, is rarely successful. In the majority of cases, chronic insomnia can be resolved if its medical or psychiatric causes are identified, and treated appropriately.
Author Jacky Van SchoorSource: SA Pharmaceutical Journal 79, pp 24 –26 (2012)More Less
A key adverse effect of poorly controlled acute pain is progression to chronic pain. The subjective nature of pain complicates the issue of pain management, both as expressed by the patient, and as interpreted by the doctor. Since categorising pain helps guide treatment, the classification of pain is discussed in some detail. Assessing pain and treating it adequately are the goals of good pain management. Although similarities exist, the pharmacological management of acute pain differs from that of chronic pain. This short review discusses the basic approach to the management of chronic non-cancer pain, and the approach to the management of cancer pain.
Author Bronwyn GreenSource: SA Pharmaceutical Journal 79, pp 28 –31 (2012)More Less
A wound is defined as an injury that causes a break in the integrity of the skin. The cause of a wound can vary. For the purpose of this article, a minor wound will be defined as a break in the integrity of the skin, in which the superficial layers of skin are affected.
Examples of minor wounds are abrasions, surgical incisions, lacerations and cuts (including surgical incisions), bites, and minor burns.
Author Leilani JohnstonSource: SA Pharmaceutical Journal 79, pp 33 –37 (2012)More Less
Keratoconjuctivitis sicca, more commonly known as dry eye, or dry eye disease, is common. It results from improper functioning of the lacrimal functional unit. First-line treatment tear substitutes, such as eye drops, gels and ointments, have an essential role. However, a newer understanding of the inflammatory aetiology of the disease has resulted in a shift in treatment strategies.
Source: SA Pharmaceutical Journal 79, pp 38 –39 (2012)More Less
Efient®, co-administered with acetylsalicylic acid (ASA), is indicated for the reduction of atherothrombotic events in patients with acute coronary syndromes who are undergoing percutaneous coronary intervention, as follows:
- Patients with unstable angina or non-ST segment elevation myocardial infarction, who are managed with percutaneous coronary intervention.
- Patients with ST-segment elevation myocardial infarction, who are managed with primary, or delayed, percutaneous coronary intervention.
Author Fatima SulemanSource: SA Pharmaceutical Journal 79, pp 40 –42 (2012)More Less
The education system in South Africa has undergone transformation since the post-apartheid period. Policy documents from the National Commission on Higher Education (NCHE) in the mid 1990s, the white paper of 1997, and the National Plan for Education (NPHE) of 2001, and beyond, have emphasised that new curricula needed to be generated, and new models of teaching and learning pursued. These are required to accommodate a larger, and more diverse, student population (NCHE, 1996; Council on Higher Education, 2004; White paper 3: a programme for higher education transformation, Department of Education, 1997; Department of Education, 2001).
Author Sarel MalanSource: SA Pharmaceutical Journal 79 (2012)More Less
Back in the days, when standing in a retail pharmacy still made up quite a percentage of my monthly working hours, the one thing that used to irritate me most was the patient, or rather client in this case, trying to teach or convince me that this new 'all natural remedy' she had read about in Huisgenoot would actually work much better for her cough than the empirically tried and tested cough syrup that I was suggesting - this of course, only after he/she had asked me for advice and medicine to relieve 'this nagging cough'. A further frustration was that in many cases, 'good' supplements, which I as a pharmacist would have liked to know more about, were advertised to the public in popular magazines at least a month before the manufacturers deemed it necessary to inform pharmacies about it.
Author Thanushya PillayeSource: SA Pharmaceutical Journal 79, pp 43 –44 (2012)More Less
It gives me great pleasure to report on the activities of the South African Association of Hospital and Institutional Pharmacists, the National Executive Committee (NEC), and the elected president for the period March 2011-February 2012.
Thank you to SAAHIP for electing me, and providing me with an opportunity to serve as President of the Association for this past year. It has been an exciting and memorable experience.
Pharmintercom 2011 : Whistler, British Columbia, Canada
Diabetes Month : pharmaceutical practitionerAuthor Johan BothmaSource: SA Pharmaceutical Journal 79, pp 45 –46 (2012)More Less
Pharmintercom is a meeting between the community pharmacist associations of major English-speaking countries, namely Australia, Canada, Ireland, New Zealand, South Africa, the United Kingdom, and the United States of America. This year, the meeting was held in the beautiful town of Whistler, British Columbia, Canada, and was chaired by the President of the Canadian Pharmacists Association, Mr Jody Shkrobot.
Source: SA Pharmaceutical Journal 79, pp 47 –49 (2012)More Less
Department of Health letter to PSF with regards to the dispensing fee
Dispensing fee review: CKS consent letter
MCC temporary posts
Promotion of Information Act
Compliments of the season
Quis custodiet ipsos custodes?
Conversations from the PSSA facebook page